SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-106757
Filing Date
2016-06-03
Accepted
2016-06-03 16:04:19
Documents
1
Period of Report
2016-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v441642_4.html 4  
1 OWNERSHIP DOCUMENT v441642_4.xml 4 3896
  Complete submission text file 0001144204-16-106757.txt   5351
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 90, FAIRMOUNT ROAD WEST CALIFON NJ 07830-3330
Business Address
Durrant Cameron (Reporting) CIK: 0001421882 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36602 | Film No.: 161695647